FIELD: chemistry.
SUBSTANCE: invention enables synthesis of 3-methoxy-2-fluoro-18ethyl-8α-gona-1,3,5(10)-trienes, having osteoprotector and hypocholesteremic activity.
EFFECT: invention has osteoprotector and hypocholesteremic activity and can be used in medicine for hormonal replacement therapy.
1 cl, 3 ex, 1 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| RACEMIC 3,17β-DIHYDROXY-7α,18-DIMETHYL-6-OXAEXTRA-1,3,5( 10 ),8(9)-TETRAENE DIACETATE EXHIBITING OSTEOPROTECTIVE, HYPOCHOLESTEREMIC AND ANTIOXIDANT ACTION | 2009 |
|
RU2422455C1 |
| METHYL ETHER OF 16,16-DIMETHYL-2-FLUORO-D-HOMO-8ALPHA-OESTRONE, HAVING HYPOLIPIDEMIC AND CARDIOPROTECTOR ACTIVITY | 2010 |
|
RU2436792C1 |
| 17,17-DIMETHYL-D-HOMO-B-NOR-8α-OESTRONE HAVING HYPOLIPIDEMIC AND CARDIOPROTECTOR ACTIVITY | 2008 |
|
RU2391351C1 |
| RACEMIC 2,17ALFABETA-DISULFAMOYLOXY-3-METHOXY-D-HOMO-8ALPHA-ESTRA-1,3,5 (10)-TRIENE AS MSF-7 TUMOR CELLS PROLIFERATION INHIBITOR | 2016 |
|
RU2629186C1 |
| RACEMIC 2,17β-DISULFOMOYLOXY-3-METHOXY-8α-EXTRA-1,3,5(10)-TRIENE AS INHIBITOR OF TUMOUR CELL PROLIFERATION OF MCF-7 | 2014 |
|
RU2562242C1 |
| 2-ETHYL-6-OXAESTRA-1,3,5(10),8,14-PENTENES SULFAMATES AS MCF-7 TUMOUR CELLS PROLIFERATION INHIBITORS | 2016 |
|
RU2620084C1 |
| 7β-METHYL-3,17αβ-DISULFAMOYLOXY-D-HOMO-6-OXA-ESTRA-1,3,5(10), 8,14-PENTAEN AS BREAST CANCER MCF-7 CELLS GROWTH INHIBITOR | 2016 |
|
RU2619457C1 |
| 3-O-SULFAMOILOXY-6-OXA-7Β-METHYL-D-HOMO-8Α-ESTRA-1,3,5(10)-TRIEN-17Α-ONE APPLICATION FOR THE BREAST CANCER TREATMENT, INCLUDING THE TRIPLE NEGATIVE FORM, AND ITS PRODUCTION METHOD | 2018 |
|
RU2679625C1 |
| RACEMIC 3-HYDROXY-16-METHYL-2-FLUORO-13a-ESTRA-1,3,5(10),8(9),15-PENTAEN-17-ONE AS MEANS OF HORMONE REPLACEMENT THERAPY AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2526264C1 |
| 16α,17α-CYCLOHEXA-17β-2'-HYDROXYETHYL)-13β-METHYLGONA-1,3,5(10)-TRIEN-3-OL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2601423C1 |
